{
    "eid": "2-s2.0-85009986044",
    "title": "Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)",
    "cover-date": "2017-03-01",
    "subject-areas": [
        {
            "$": "Radiology",
            "@code": "2741"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Radiation",
            "@code": "3108"
        },
        {
            "$": "Cancer Research",
            "@code": "1306"
        }
    ],
    "keywords": [],
    "authors": [
        "Loren K. Mell"
    ],
    "citedby-count": 130,
    "ref-count": 30,
    "ref-list": [
        "Global cancer statistics",
        "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma",
        "Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG) 90-01",
        "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix",
        "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer",
        "Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis",
        "Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix",
        "Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study",
        "Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors",
        "Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies",
        "Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients",
        "Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy",
        "Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies",
        "Clinical Outcomes of Definitive Intensity-Modulated Radiation Therapy With Fluorodeoxyglucose-Positron Emission Tomography Simulation in Patients With Locally Advanced Cervical Cancer",
        "Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: A prospective randomized study",
        "Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin",
        "Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy",
        "Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy",
        null,
        "Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies",
        "A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy",
        null,
        "Optimized planning target volume for intact cervical cancer",
        "Comparison of Treatment Tolerance and Outcomes in Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy in a Prospective Randomized Trial or With Standard Treatment",
        "A test of missing completely at random for multivariate data with missing values",
        "Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer",
        "A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation therapy oncology group trial 0418",
        "Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial",
        "Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients - Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group",
        "Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies"
    ],
    "affiliation": [
        {
            "affiliation-city": "La Jolla",
            "affilname": "University of California, San Diego",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Gliwice",
            "affilname": "Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Xi'an",
            "affilname": "Xijing Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": null,
            "affilname": "Permanente Medical Group",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "St. Louis",
            "affilname": "Washington University School of Medicine in St. Louis",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Mumbai",
            "affilname": "Tata Memorial Hospital",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Hradec Kralove",
            "affilname": "Fakultn\u00ed Nemocnice Hradec Kr\u00e1lov\u00e9",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Houston",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "St. Louis",
            "affilname": "Washington University in St. Louis",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "National Center for Advancing Translational Sciences"
    ]
}